N-(N-Benzylpiperidin-4-yl)-2-[18f]fluorobenzamide: A potential ligand for PET imaging of σ receptors

Nuclear Medicine and Biology

Volumn 24, Issue 7, 1997, Pages 671-676

  Shiue, Chyng Yann ^a   Shiue, Grace G ^a   Zhang, Sue X ^a   Wilder, Susan ^a   Greenberg, Joel H ^a   Benard, Francois ^a   Wortman, Jeffrey A ^a   Alavi, Abass A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Fluorobenzamide; PET imaging; Radioligand; Sigma receptors

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENZAMIDE DERIVATIVE; DIMETHYL SULFOXIDE; FLUORINE 18; GLUTAMIC ACID; HALOPERIDOL; KETANSERIN; N METHYL DEXTRO ASPARTIC ACID; PENTAZOCINE; PIPERIDINE DERIVATIVE; PRAZOSIN; RADIOLIGAND; SEROTONIN; SIGMA OPIATE RECEPTOR; SULPIRIDE; TETRAHYDROFURAN; TRIETHYLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DISTRIBUTION; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; GUINEA PIG; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIGAND BINDING; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; RECEPTOR AFFINITY;

ANIMALS; BENZAMIDES; BRAIN; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUORINE RADIOISOTOPES; GUINEA PIGS; ISOTOPE LABELING; LIGANDS; MALE; MICE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; SPECTROPHOTOMETRY, ULTRAVIOLET; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030861403     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00097-8     Document Type: Article

References (50)

1. 1 receptor antagonists. Eur. J. Pharmacol. 219, 45-52.
2. Bem W. T., Thomas G. E., Mamone J. Y., Homan S. M., Levy B. K., Johnson F. E. and Coscia C. J. (1991) Overexpression of sigma receptors in nonneural human tumors. Cancer Res. 51, 6558-6562.
3. 1 receptor antagonist ligand, in rat striatum. Life Sci. 35, 1885-1893.
4. Booth R. G., Kula N. S., Myers A. M., Baldessarini R. J., Mailman R. B. and Wyrick S. D. (1993) A new sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies. Mol. Pharmacol. 44, 1232-1239.
5. Chaki S., Tanaka M., Muramatsu M. and Otomo S. (1994) NE-100, a novel potent σ ligand, preferentially binds to σ-1 binding sites in guinea pig brain. Eur. J. Pharmacol. 251, R1-R2.
6. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
7. 18F]-1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine. J. Label. Campds. Radiopharm. 38, 785-794.
8. 3H]haloperidol in rat brain. Neurosci. Lett. 75, 133-140.
9. Ding Y.-S., Fowler J. S., Dewey S. L., Wolf A. P., Logan J., Gatley S. J., Volkow N. D., Shea C. and Taylor D. P. (1993) Synthesis and PET studies of fluorine-18-BMY 14802: A potential antipsychotic drug. J. Nucl. Med. 34, 246-254.
10. Ferris C. D., Hirsch D. J., Brooks B. P. and Snyder S. H. (1991) σ receptors: From molecule to man. J. Neurochem. 57, 729-737.
11. 3H]-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J. Neurosci. 6, 1757-1770.
12. 3H]phencyclidine in brain membranes. Life Sci. 30, 2147-2154.
13. Hashimoto K. and London E. D. (1994) Imaging σ receptors and cerebral responses to σ drugs. In: Sigma Receptors (Edited by Itzhak Y.), pp. 225-242. Academic Press, San Diego, CA.
14. 3H]sulpiride binding sites in rat striatal membranes. Brain Res. 402, 331-338.
15. John C. S., Bowen W. D., Saga T., Kinuya S., Vilner B. J., Baumgold J., Paik C. H., Reba R. C., Neumann R. D., Varma V. M. and McAfee J. G. (1993) A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)-4-iodobenzamide. J. Nucl. Med. 34, 2169-2175.
16. 125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide, a new sigma receptor radiopharmaceutical: High-affinity binding to MCF-7 breast tumor cells. J. Med. Chem. 37, 1737-1739.
17. 125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: A high affinity σ receptor ligand for potential imaging of breast cancer. Cancer Res. 55, 3022-3027.
18. John C. S., Vilner B. J., Schwartz A. M. and Bowen W. D. (1996) Characterization of sigma receptor binding sites in human biopsied solid breast tumors. J. Nucl. Med. 37(suppl), 1-267.
19. 3H]TCP binding: Effects of glycine, magnesium, and NMDA agonists. Eur. J. Pharmocol. 152, 141-146.
20. 3H](+)-3-PPP label pharmacologically distinct σ binding sites in guinea pig brain membranes. Eur. J. Pharmacol. 193, 21-27.
21. 4-2-([3,4-dichlorophenyl]ethyl)piperazine, a high affinity ligand for sigma receptor. J. Label. Compd. Radiopharm. 33, 639-643.
22. Largent B. L., Wikström H., Snowman A. M. and Snyder S. H. (1988) Novel antipsychotic drugs share high affinity for σ receptors. Eur. J. Pharmacol. 155, 345-347.
23. 3H]Ketanserin: A selective tritiated ligand for serotonin-2 receptor binding sites. Mol. Pharmacol. 21, 301-314.
24. Martin W. R., Eades C. E., Thompson J. A. and Huppler R. E. (1976) The effects of morphine and nalorphine-like drugs in the nondependent and morphine dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517-532.
25. McCann D. J., Weissman A. D. and Su T. P. (1994) Sigma-1 and sigma-2 sites in rat brain: Comparison of regional, ontogenetic, and subcellular patterns. Synapse 17, 182-189.
26. Michelot J. M., Morean M. F. C., Bonafous J. F., Bacin F. L., Madelmont J. C., Bussicrc F., Souteyrand P. A., Mauclaire L. P., Chossat F. M., Papon J. M., Labarre P. G., Kauffmann P. and Plagne R. J. (1993) Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl-4-iodobenzamide). J. Nucl. Med. 34, 1260-1266.
27. 11C]-benzyl-N-normetazocine. J. Label. Compd. Radiopharm. 34, 49-57.
28. 3H]RX821002 to alpha-2 adrenergic receptor subtypes. J. Pharmacol. Exp. Ther. 268, 1362-1367.
29. 3H]-spiroperidol. Mol. Pharmacol. 18, 687-699.
30. 1H-indoles. J. Med. Chem. 38, 1998-2008.
31. Quirion R., Bowen W. D., Itzhak Y., Junien J. L., Musacchio J. M., Rothman R. B., Su T. P., Tam W. and Taylor D. P. (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13, 85-86.
32. Quirion R., Chicheportiche R., Contreras P. C., Johnson K. M., Lodge D., Tam S. W., Woods J. H. and Zukin S. R. (1987) Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Neurosci. 10, 444-446.
33. 3H]idazosan. J. Neural. Transm. 68, 79-95.
34. 18F]haloperidol. Synapse 11, 10-19.
35. Shibuya H., Mori H. and Toru M. (1992) Sigma receptors in schizophrenic cerebral cortices. Neurochem. Res. 17, 983-990.
36. 18F-labeled butyrophenone neuroleptics: Benperidol, haloperidol, spiroperidol, and pipamperone. J. Nucl. Med. 26, 181-186.
37. 18F]BMY 14802, its enantiomers and their anatomical distribution in rodents. Nucl. Med. Biol. 20, 625-630.
38. 18F]fluoro analog as sigma receptor ligands for PET studies. J. Nucl. Med. 36(suppl), 151.
39. Snyder S. H. and Largent B. L. (1989) Receptor mechanisms in antipsychotic drug action: Focus on sigma receptcrs. J. Neuropsych. 1, 7-15.
40. 3H]SKF 10047 to etorphine-inaccessible sites in guinea pig brain. J. Pharmacol. Exp. They. 223, 284-290.
41. Su T. P. (1991) σ receptors: Putative links between nervous, endocrine and immune systems. Eur. J. Biochem. 200, 633-642.
42. Su T. P. (1993) Delineating biochemical and functional properties of sigma receptors: Emerging concepts. Crit. Rev. Neurobiol. 7, 187-203.
43. 1-adrenoreptors. Mol. Pharmacol. 20, 295-301.
44. 2 receptors in the rat striatum. J. Pharm. Pharmacol. 44, 911-914.
45. 3H]TCP: A new tool with high affinity for the PCP receptor in rat brain. Brain Res. 280, 194-197.
46. Vilner B. J., John C. S. and Bowen W. D. (1995) Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 55, 408-413.
47. Walker J. M., Bowen W. D., Walker F. O., Matsumoto R. R., de Costa B. and Rice K. C. (1990) Sigma receptors: Biology and function. Pharmacol. Rev. 42, 355-402.
48. Weissman A. D., Su T. P., Hedreen J. C. and London E. D. (1988) Sigma receptors in post-mortem human brains. J. Pharmacol. Exp. Ther. 247, 29-33.
49. 18F-labeled guanidines. J. Med. Chem. 34, 1867-1870.
50. Wong D. F., Gibson R., Burns H. D., Dannals, R. F., Shay E., London E. D., Brenner N., Wilson A. A., Ravert H. T., Chen C., Minkin E., and Wagner H. N. Jr. (1991) In vivo imaging of sigma receptors in primate brain. J. Nucl. Med. 32, 1071.